`Prussia Declaration
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`
`____________________________________________
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`____________________________________________
`
`PFIZER, INC.,
`Petitioner,
`
`v.
`
`GENENTECH, INC.,
`Patent Owner.
`____________________________________________
`
`Case IPR2017-01489
`U.S. Patent 6,407,213
`____________________________________________
`
`DECLARATION OF KEVIN S. PRUSSIA IN SUPPORT OF
`MOTION FOR ADMISSION PRO HAC VICE
`
`Genentech 2037
`Pfizer v. Genentech
`IPR2017-01489
`
`
`
`
`
`I, Kevin S. Prussia, declare as follows:
`
`
`
`Case No. IPR2017-01489
`Prussia Declaration
`
`1.
`
`I obtained a B.A. from New York University in 2001, and a J.D. from
`
`the Boston University School of Law in 2006.
`
`2.
`
`I am currently a partner in the law firm of Wilmer Cutler Pickering
`
`Hale and Dorr LLP, a position which I have held since January 1, 2015. In my 10
`
`years of law practice, I have focused primarily on representing clients in patent
`
`litigations involving the chemical and pharmaceutical arts in United States district
`
`courts and the Court of Appeals for the Federal Circuit. Through this work, I have
`
`gained extensive experience as a litigating attorney, particularly in patent cases.
`
`3.
`
`I am a member in good standing of the Bars of the Commonwealth of
`
`Massachusetts and the State of New York. I am admitted to practice before the
`
`U.S. District Court for the District of Massachusetts. I am also admitted to practice
`
`before the U.S. Court of Appeals for the First Circuit, and the U.S. Court of
`
`Appeals for the Federal Circuit. I am also admitted to practice before the Supreme
`
`Judicial Court for Suffolk County, Massachusetts, and the State of New York
`
`Supreme Court Appellate Division, Third Judicial Dept.
`
`4. My Massachusetts Bar membership number is 666813.
`
`5.
`
`In the past three years, I have appeared pro hac vice before the Office
`
`in the following proceedings: ASML Netherlands BV, et al. v. Energetiq Tech.,
`
`
`
`
`1
`
`
`
`
`
`
`Inc., IPR2015-01300 (pro hac vice granted); ASML Netherlands BV, et al. v.
`
`Case No. IPR2017-01489
`Prussia Declaration
`
`Energetiq Tech., Inc., IPR2015-01377 (pro hac vice granted); ASML Netherlands
`
`BV, et al. v. Energetiq Tech., Inc., IPR2015-01279 (pro hac vice granted); ASML
`
`Netherlands BV, et al. v. Energetiq Tech., Inc., IPR2015-01277 (pro hac vice
`
`granted); ASML Netherlands BV, et al. v. Energetiq Tech., Inc., IPR2015-01368
`
`(pro hac vice granted); ASML Netherlands BV, et al. v. Energetiq Tech., Inc.,
`
`IPR2015-01362 (pro hac vice granted); ASML Netherlands BV, et al. v. Energetiq
`
`Tech., Inc., IPR2015-01375 (pro hac vice granted); Coalition for Affordable
`
`Drugs VII, LLC v. The Trustees of U. Penn., IPR2015-01835 (pro hac vice
`
`granted); Coalition for Affordable Drugs VII, LLC v. The Trustees of U. Penn.,
`
`IPR2015-01836 (pro hac vice granted). I represent Patent Owner Genentech, Inc.
`
`in a number of pending IPR proceedings, including IPR2017-00731 (pro hac vice
`
`filed June 8, 2017; institution denied July 27, 2017, request for rehearing filed
`
`August 25, 2017); IPR2017-00737 (pro hac vice granted June 21, 2017; trial
`
`instituted July 27, 2017); IPR2017-00739 (pro hac vice granted June 21, 2017;
`
`institution denied July 27, 2017); IPR2017-00804 (pro hac vice filed June 8, 2017;
`
`trial instituted July 27, 2017); IPR2017-00805 (pro hac vice granted filed June 8,
`
`2017; trial instituted July 27, 2017); IPR2017-01121 (pro hac vice motion to be
`
`filed, pending); IPR2017-01122 (pro hac vice motion to be filed, pending);
`
`IPR2017-01139 (pro hac vice motion to be filed, pending); IPR2017-01140 (pro
`
`
`
`
`2
`
`
`
`
`
`
`hac vice motion to be filed, pending); IPR2017-01373 (pro hac vice motion to be
`
`Case No. IPR2017-01489
`Prussia Declaration
`
`filed, pending); IPR2017-01374 (pro hac vice motion to be filed, pending);
`
`IPR2017-01489 (pro hac vice motion to be filed, pending); IPR2017-01726 (pro
`
`hac vice motion to be filed, pending); IPR2017-01727 (pro hac vice motion to be
`
`filed, pending); IPR2017-01958 (pro hac vice motion to be filed, pending);
`
`IPR2017-01959 (pro hac vice motion to be filed, pending); IPR2017-01960 (pro
`
`hac vice motion to be filed, pending).
`
`6.
`
`I have an established familiarity with the subject matter of the U.S.
`
`Patent No. 6,407,213 (the ’213 patent), the ’213 patent’s file history, and the prior
`
`art at issue in this proceeding. I have been representing Genentech in connection
`
`with intellectual property matters relating to antibodies since early 2016. See
`
`Sanofi-Aventis U.S. LLC et al. v. Genentech, Inc. et al., Case No. 2:15-cv-05685-
`
`GW-AGR (C.D. Cal.); Merck Sharp & Dohme Corp. v. Genentech, Inc. et al., No.
`
`16-cv-04992 (C.D. Cal.).
`
`7.
`
`I have never been suspended or disbarred from practice before any
`
`court or administrative body.
`
`8.
`
`I have never had a court or administrative body deny my application
`
`for admission to practice.
`
`9.
`
`I have never had any sanctions or contempt citations imposed on me
`
`by any court or administrative body.
`
`
`
`
`3
`
`
`
`
`
`10.
`
`I have read and will comply with Office Patent Trial Practice Guide
`
`Case No. IPR2017-01489
`Prussia Declaration
`
`
`
`and the Board’s Rules of Practice for Trials, as set forth in 37 C.F.R. Part 42.
`
`11.
`
`I agree to be subject to the United States Patent and Trademark Office
`
`Rules of Professional Conduct set forth in 37 C.F.R. §§ 11.101 et seq. and
`
`disciplinary jurisdiction under 37 C.F.R. § 11.19(a).
`
`I hereby declare that all statements made herein of my own knowledge are
`
`true and that all statements made on information and belief are believed to be true;
`
`and further that these statements are made with the knowledge that willful false
`
`statements and the like are punishable by fine, imprisonment, or both, under
`
`Section 1001 of Title 18 of the United States Code.
`
`
`
`
`Respectfully submitted,
`
`
`/Kevin S. Prussia/
`Kevin S. Prussia
`WILMER CUTLER PICKERING
`HALE AND DORR LLP
`60 State Street
`Boston, MA 02109
`Kevin.Prussia@wilmerhale.com
`Tel.: 617-526-6243
`Fax: 617-526-5000
`
`4
`
`
`
`Dated: September 22, 2017
`
`
`
`
`
`
`
`
`